EUVIMEDOpdag EUVIMED
KorrekturOpen access · CC BY 4.0

Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”

Advanced Science · 2026-06 · 13 (33)

DOI: 10.1002/advs.75571 ↗

At a glance

Korrektur in Advanced Science, published online on 2026-05-07. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Cite

APA

(2026). Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science, 13(33). https://doi.org/10.1002/advs.75571

Vancouver

Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science. 2026;13(33). doi:10.1002/advs.75571

BibTeX
@article{euvimed2026,
  title = {Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {33},
  doi = {10.1002/advs.75571}
}
Start for free →